CORXEL Pharmaceuticals (Shanghai) Co., Ltd.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regeneron Bolsters Ophthalmic Portfoli

Biotech financing deals in China, backed by venture capital and private equity firms, started to pick up in January and deal sizes also crossed the CNY200m ($28m) mark. Apart from Ji Xing Pharmaceuti

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Ikena Cuts Back As BMS Unravels Partner

Venture capital fundraising by biopharmaceutical companies plunged in the fourth quarter to $4.3bn, down from $6.2bn in the third quarter and below the $5.7bn raised in Q4 of 2022, according to the la